BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29367428)

  • 1. Krüppel-like Factor 4 Suppresses Serine/Threonine Kinase 33 Activation and Metastasis of Gastric Cancer through Reversing Epithelial-Mesenchymal Transition.
    Kong F; Sun T; Kong X; Xie D; Li Z; Xie K
    Clin Cancer Res; 2018 May; 24(10):2440-2451. PubMed ID: 29367428
    [No Abstract]   [Full Text] [Related]  

  • 2. PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer.
    Zhang J; Zhu Z; Wu H; Yu Z; Rong Z; Luo Z; Xu Y; Huang K; Qiu Z; Huang C
    Gastric Cancer; 2019 Jan; 22(1):48-59. PubMed ID: 29748877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
    Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
    Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Regulation of Kruppel-Like Factor 4 on microRNA-106a at Upstream Transcriptional Level and the Role in Gastric Cancer Metastasis.
    Zhu M; Zhang N; Lu X; He S
    Dig Dis Sci; 2018 Oct; 63(10):2604-2616. PubMed ID: 29948558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer.
    Zheng J; Liu Y; Qiao Y; Zhang L; Lu S
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28445396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Novel KLF4/MSI2 Signaling Pathway Regulates Growth and Metastasis of Pancreatic Cancer.
    Guo K; Cui J; Quan M; Xie D; Jia Z; Wei D; Wang L; Gao Y; Ma Q; Xie K
    Clin Cancer Res; 2017 Feb; 23(3):687-696. PubMed ID: 27449499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 4 negatively regulates β-catenin expression and inhibits the proliferation, invasion and metastasis of gastric cancer.
    Zhang N; Zhang J; Shuai L; Zha L; He M; Huang Z; Wang Z
    Int J Oncol; 2012 Jun; 40(6):2038-48. PubMed ID: 22407433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
    Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
    J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
    Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
    J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulation of MicroRNA-375 Inhibits Proliferation and Migration in Gastric Cancer in Association With Autophagy-Mediated AKT/mTOR Signaling Pathways.
    Yuan KT; Li BX; Yuan YJ; Tan M; Tan JF; Dai WG; Feng WD; Zuo JD
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806499. PubMed ID: 30355273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STK33 plays an important positive role in the development of human large cell lung cancers with variable metastatic potential.
    Wang P; Cheng H; Wu J; Yan A; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):214-23. PubMed ID: 25662617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1α signaling.
    Zhou Y; Xu Q; Shang J; Lu L; Chen G
    J Cell Physiol; 2019 Aug; 234(10):17876-17885. PubMed ID: 30851060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
    Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
    Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Lipoxygenase promotes epithelial-mesenchymal transition through the ERK signaling pathway in gastric cancer.
    Lin H; Weng J; Mei H; Zhuang M; Xiao X; Du F; Lin L; Wu J; Chen Z; Huang Y; Chen F; Wang X
    J Gastroenterol Hepatol; 2021 Feb; 36(2):455-466. PubMed ID: 32667711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.